Irvine, Calif., May 27, 2014 — A discovery by UC Irvine endocrinologists about the importance of cell surface receptors for estrogen has the potential to change how researchers view the hormone's role in normal organ development and function.
To date, scientists in the field focused on receptors in the cell's nucleus as the primary site for estrogen's effect on gene activity and organ development and function. There has been acknowledgement of similar estrogen receptors outside of the nucleus but much debate as to whether they are important.
To investigate this, Dr. Ellis Levin, professor of medicine at UC Irvine, employed a knock-in mouse that prevented the main estrogen receptor, ER-alpha, from trafficking to the cell membrane.
As a result, Levin found that many organs in the female mice were extremely abnormal, including the mammary gland, uterus, and ovaries. Additionally, pituitary hormone production and fat development were also severely impacted, and the mice were completely infertile.
"Until now, research has taken a narrow view on the importance of estrogen signaling outside the nucleus during development," Levin said. "What this study shows is that both nuclear and cell membrane estrogen receptors are required to collaborate for normal organ development and function."
The implications of this discover move beyond development, Levin added, and can include estrogen's role in causing cancers, or preventing cardiovascular diseases and bone diseases. Current therapeutic efforts propose to target estrogen's ability in the nucleus to turn genes on and off, but Levin notes new approaches should also explore irregularities of functions at cell membrane receptors that affect disease.
"The cell membrane receptor is very sophisticated, impacting the nuclear receptor action and modifying certain proteins and their functions throughout the cells of many organs," Levin said. "By studying how to regulate the partnership between these two receptor sets, and modulate membrane receptor signaling, we can understand how to better treat estrogen-linked diseases and gain benefits in other aspects."
Study results appear in Developmental Cell. Ali Pedram of UC Irvine; Mahnaz Razandi with the Veterans Affairs Medical Center of Long Beach, Calif.; Michael Lewis with the Baylor College of Medicine in Houston; and Stephen Hammes with the University of Rochester, contributed to the study, which received support from a Merit Review Award from the Department of Veterans Affairs and the National Institutes of Health (grant 2RO1CA100366).
About the University of California, Irvine: Located in coastal Orange County, near a thriving employment hub in one of the nation's safest cities, UC Irvine was founded in 1965. One of only 62 members of the Association of American Universities, it's ranked first among U.S. universities under 50 years old by the London-based Times Higher Education. The campus has produced three Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Michael Drake since 2005, UC Irvine has more than 28,000 students and offers 192 degree programs. It's Orange County's second-largest employer, contributing $4.3 billion annually to the local economy.
Media access: UC Irvine maintains an online directory of faculty available as experts to the media at today.uci.edu/experts. Radio programs/stations may, for a fee, use an on-campus ISDN line to interview UC Irvine faculty and experts, subject to availability and university approval. For more UC Irvine news, visit news.uci.edu. Additional resources for journalists may be found at communications.uci.edu/for-journalists.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.